Hemoadsorption in the critically ill - Final results of the International CytoSorb Registry
Pubblicato in: | PLoS One 17(2022)10, S. e0274315 |
---|---|
Autori principali: | Hawchar, Fatime (Autore), Tomescu, Dana (Autore), Henzler, Dietrich (Autore) |
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
2022
|
Soggetti: | |
Accesso online: | https://doi.org/10.1371/journal.pone.0274315 |
Documenti correlati: | In:
PLoS One |
Documenti analoghi
-
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
di: Köhler, Thomas, et al.
Pubblicazione: (2021) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
di: Köhler, Thomas, et al.
Pubblicazione: (2022) -
Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb-Basics, Indications and Perspectives-A Scoping Review
di: Köhler, Thomas, et al.
Pubblicazione: (2021) -
High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock : a retrospective cohort study
di: Schultz, Philipp, et al.
Pubblicazione: (2021) -
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry
di: Al-Batran, Salah-Eddin, et al.
Pubblicazione: (2021)